Search

Your search keyword '"Moretti, Luciano"' showing total 155 results

Search Constraints

Start Over You searched for: Author "Moretti, Luciano" Remove constraint Author: "Moretti, Luciano"
155 results on '"Moretti, Luciano"'

Search Results

1. Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry

3. Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry

5. The 'Life Potential': a new complex algorithm to assess 'Heart Rate Variability' from Holter records for cognitive and diagnostic aims. Preliminary experimental results showing its dependence on age, gender and health conditions

6. Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial

7. “Full-plastic jacket” with everolimus-eluting Absorb bioresorbable vascular scaffolds: Clinical outcomes in the multicenter prospective RAI registry (ClinicalTrials.gov Identifier: NCT02298413)

8. Clinical findings after bioresorbable vascular scaffold implantation in an unrestricted cohort of patients with ST-segment elevation myocardial infarction (from the RAI registry)

9. Patients with non-ST segment elevation acute coronary syndromes managed without coronary revascularization: A population needing treatment improvement

10. Thirty-Day Outcomes After Unrestricted Implantation of Bioresorbable Vascular Scaffold (from the Prospective RAI Registry)

13. Effect of Pre-Hospital Ticagrelor During the First 24 h After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction: The ATLANTIC-H24 Analysis

14. Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy: The RESTYLE-HCM Randomized, Double-Blind, Placebo-Controlled Study

15. Clinical outcomes of overlapping versus non‐overlapping everolimus‐eluting absorb bioresorbable vascular scaffolds: An analysis from the multicentre prospective RAI registry (ClinicalTrials.gov identifier: NCT02298413)

16. Urine alkalinisation to prevent contrast-induced acute kidney injury: the prospective, randomised, controlled, open-label TEATE trial

17. Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry (Clinical Research in Cardiology, (2022), 111, 5, (560-573), 10.1007/s00392-022-01996-2)

19. 651 Prevention of contrast induced nephropathy with urine alkalinization: the final results of the TEATE study

20. A New World System from the Global South: Great Convergence and Accelerated Geographic Displacement

26. Divergent Convergence: Complementing Theoretical Approaches for Understanding the Rise of the Global South and the Challenges for "the Rest".

28. Early Autologous Stem-Cell Transplantation Versus Conventional Chemotherapy as Front-Line Therapy in High-Risk, Aggressive Non-Hodgkin’s Lymphoma: An Italian Multicenter Randomized Trial

29. Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX

30. Randomized Trial of Fludarabine Versus Fludarabine and Idarubicin as Frontline Treatment in Patients With Indolent or Mantle-Cell Lymphoma

31. Abstract 808: Functional Characterization of a Novel Scn5a Mutation Associated With the Brugada Syndrome

34. Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial

35. One-year clinical outcomes after unrestricted implantation of the Absorb bioresorbable scaffold (RAI registry)

36. A comparison of 8‐mm and open‐irrigated gold‐tip catheters for typical atrial flutter ablation: Data from a prospective multicenter registry

37. Elderly Aggressive-Histology Non-Hodgkin's Lymphoma: First-Line VNCOP-B Regimen Experience on 350 Patients

38. TCT-248 Absorb bioresorbable vascular scaffold in patients with or without diabetes mellitus: a sub-analysis of the Italian multicenter RAI Registry ( ClinicalTrials.gov Identifier: NCT02298413)

39. Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management

40. TCTAP A-004 Early Clinical Outcomes Following “Off-” Versus “On-label” Indications of Bioresorbable Vascular Scaffolds for the Treatment of 1505 Patients with Coronary Artery Disease: Results from the Prospective “Registro Absorb Italiano” (RAI Registry)

41. TCTAP A-001 Thirty-day Clinical Outcomes Following Bioresorbable Vascular Scaffold Implantation in Patients Presenting with Acute Coronary Syndromes Versus Stable Coronary Artery Disease: Results from the Italian RAI Registry

42. Association of acute kidney injury and bleeding events with mortality after radial or femoral access in patients with acute coronary syndrome undergoing invasive management: secondary analysis of a randomized clinical trial.

43. One‐year clinical performance of ABSORB bioresorbable vascular scaffold in patients presenting with acute coronary syndromes: Results from the RAI registry.

44. TCT-425 Bioresorbable vascular scaffold technology for small vessel coronary artery disease: results from the Italian multicenter RAI Registry

45. TCT-408 Thirty-day Outcome Following Polymeric Bioresorbable Scaffold Implantation in 347 STEMI Patients Enrolled in the Multicenter “Registro Absorb Italiano” (RAI Registry)

46. TCT-417 Bioresorbable vascular scaffold in chronic total coronary artery occlusions: results from the RAI registry

50. Effect of Pre-Hospital Ticagrelor During the First 24 h After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction

Catalog

Books, media, physical & digital resources